Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial - The Lancet Diabetes & Endocrinology
Por um escritor misterioso
Descrição
PDF) Recent advances in graves ophthalmopathy medical therapy: a
High Serum Cholesterol Is a Novel Risk Factor for Graves
Proposal for Standardization of Primary and Secondary Outcomes in
Statins and Risk of New-Onset Diabetes Mellitus
PDF) Proof-of-Concept and Randomized, Placebo-Controlled Trials of
Management of thyroid eye disease: a Consensus Statement by the
Management of thyroid eye disease: a Consensus Statement by the
Lipid lowering effects of the CETP inhibitor obicetrapib in
Proposal for Standardization of Primary and Secondary Outcomes in
Current concepts regarding Graves' orbitopathy - Bartalena - 2022
Proposal for Standardization of Primary and Secondary Outcomes in
Biomedicines, Free Full-Text
Proposal for Standardization of Primary and Secondary Outcomes in
de
por adulto (o preço varia de acordo com o tamanho do grupo)
